Showing results (271-280 of 436) with videos related to
Sort By:
Pageof 44
Blood|October 20, 2007
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myelomaJumei Shi, Guido J Tricot, Tarun K Garg, et al.Plos One|February 2, 2013
Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levelsKatie Stone, Emily Woods, Susann M Szmania, et al.Cancer Research|December 26, 2003
High heparanase activity in multiple myeloma is associated with elevated microvessel densityThomas Kelly, Hua-Quan Miao, Yang Yang, et al.British Journal of Haematology|September 12, 2008
Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myelomaSundar Jagannath, Bart Barlogie, James R Berenson, et al.Blood|April 24, 2004
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myelomaChristopher A Maxwell, Erik Rasmussen, Fenghuang Zhan, et al.British Journal of Haematology|August 26, 2004
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulationMaurizio Zangari, Bart Barlogie, Elias Anaissie, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myelomaSusann Szmania, Sacha Gnjatic, Guido Tricot, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancerRamón Rami-Porta, Vanessa Bolejack, Dorothy J Giroux, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancerPieter E Postmus, Elisabeth Brambilla, Kari Chansky, et al.Plos One|September 26, 2013
Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myelomaBo Hu, Yu Chen, Saad Z Usmani, et al.Pageof 44